Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kjersti Flatmark

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
Radiation Oncology (London, England)|August 5, 2006
Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibitionKjersti Flatmark, Ragnhild V Nome, Sigurd Folkvord, et al.
Amino Acids|March 2, 2010
Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinomaGisle Berge, Daniela Elena Costea, Marianne Berg, et al.
Journal of Surgical Oncology|April 3, 2003
Detection of disseminated tumour cells in bone marrow of patients with isolated liver metastases from colorectal cancerKristin Bjørnland, Kjersti Flatmark, Tom Mala, et al.
Acta Oncologica (Stockholm, Sweden)|December 27, 2019
Immune stimulatory effect of anti-EpCAM immunotoxin - improved overall survival of metastatic colorectal cancer patientsYvonne Andersson, Else Marit Inderberg, Gunnar Kvalheim, et al.
Plos One|January 18, 2013
Nuclear legumain activity in colorectal cancerMads H Haugen, Harald T Johansen, Solveig J Pettersen, et al.
The Lancet. Oncology|April 10, 2010
Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 studyAnne Hansen Ree, Svein Dueland, Sigurd Folkvord, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 16, 2023
Intraperitoneal administration of cabazitaxel-loaded nanoparticles in peritoneal metastasis modelsAstrid Hyldbakk, Karianne Giller Fleten, Sofie Snipstad, et al.
BMC Cancer|July 3, 2007
Pseudomyxoma peritonei--two novel orthotopic mouse models portray the PMCA-I histopathologic subtypeKjersti Flatmark, Wenche Reed, Thomas Halvorsen, et al.
Translational Oncology|May 25, 2020
Experimental Treatment of Mucinous Peritoneal Metastases Using Patient-Derived Xenograft ModelsKarianne Giller Fleten, Christin Lund-Andersen, Stein Waagene, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 12, 2026
Limited clinical utility of mutation-based circulating tumor DNA detection in pseudomyxoma peritoneiAnnette Torgunrud, Ben Davidson, Thale Andrea Nilsen, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
Radiation Oncology (London, England)|August 5, 2006
Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibitionKjersti Flatmark, Ragnhild V Nome, Sigurd Folkvord, et al.
Amino Acids|March 2, 2010
Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinomaGisle Berge, Daniela Elena Costea, Marianne Berg, et al.
Journal of Surgical Oncology|April 3, 2003
Detection of disseminated tumour cells in bone marrow of patients with isolated liver metastases from colorectal cancerKristin Bjørnland, Kjersti Flatmark, Tom Mala, et al.
Acta Oncologica (Stockholm, Sweden)|December 27, 2019
Immune stimulatory effect of anti-EpCAM immunotoxin - improved overall survival of metastatic colorectal cancer patientsYvonne Andersson, Else Marit Inderberg, Gunnar Kvalheim, et al.
Plos One|January 18, 2013
Nuclear legumain activity in colorectal cancerMads H Haugen, Harald T Johansen, Solveig J Pettersen, et al.
The Lancet. Oncology|April 10, 2010
Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 studyAnne Hansen Ree, Svein Dueland, Sigurd Folkvord, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 16, 2023
Intraperitoneal administration of cabazitaxel-loaded nanoparticles in peritoneal metastasis modelsAstrid Hyldbakk, Karianne Giller Fleten, Sofie Snipstad, et al.
BMC Cancer|July 3, 2007
Pseudomyxoma peritonei--two novel orthotopic mouse models portray the PMCA-I histopathologic subtypeKjersti Flatmark, Wenche Reed, Thomas Halvorsen, et al.
Translational Oncology|May 25, 2020
Experimental Treatment of Mucinous Peritoneal Metastases Using Patient-Derived Xenograft ModelsKarianne Giller Fleten, Christin Lund-Andersen, Stein Waagene, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 12, 2026
Limited clinical utility of mutation-based circulating tumor DNA detection in pseudomyxoma peritoneiAnnette Torgunrud, Ben Davidson, Thale Andrea Nilsen, et al.
Pageof 14